ApprovalTrail

Approval · Notice of Compliance 5241 · 1995

TRAVASE: Notice of Compliance 5241

Issued August 4, 1995

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
5241
Date
August 4, 1995
Company
Knoll Pharma Inc.Markham, Ontario, Canada
Product type
Biologic
Submission
New Drug Submission (NDS)
Submission class
Admin
Therapeutic class
Enzymatic debriding agent

Products in this notice

BrandDINStatus today
TRAVASE02178850—

Medicinal ingredients